Erythrocyte metallothionein as an index of zinc status in humans.
Metallothionein concentrations in erythrocyte lysates derived from human subjects were measured by an ELISA procedure. IgG obtained from serum of sheep injected with human metallothionein 1 was used in this competitive assay. Subjects were fed a semipurified zinc-deficient diet (0.7 mg of zinc per kg of diet) for an 8-day depletion period after 3 days of acclimation. Fasting plasma zinc concentrations were reduced approximately 7%. Metallothionein in the erythrocyte lysates was significantly decreased to 59% of the initial level by the end of the depletion period. Supplementation of these depleted subjects with zinc (50 mg) did not increase erythrocyte metallothionein levels within 24 hr. Daily supplementation of control subjects with zinc (50 mg/day) increased erythrocyte metallothionein to a 7-fold maximum within 7 days. These levels were reduced by 61% within 14 days after zinc supplementation was terminated. Incubation of rat [35S]metallothionein with human erythrocyte lysate showed a time-dependent increase in 35S soluble in 20% trichloroacetic acid, indicating degradation of the labeled protein, presumably via protease activity in the lysate. It is proposed that zinc supplementation induces erythrocyte metallothionein during erythropoiesis and that low zinc intake decreases synthesis and/or accelerates degradation of the protein in reticulocytes/erythrocytes. Metallothionein levels in erythrocytes may provide a useful index upon which to assess zinc status in humans.
Grider
A
A
Food Science and Human Nutrition Department, University of Florida, Gainesville 32611.
Bailey
L B
LB
Cousins
R J
RJ
D000328:Adult; D000818:Animals; D015415:Biomarkers / Q000097:blood*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D008297:Male; D008668:Metallothionein / Q000097:blood*; D051381:Rats; D015032:Zinc / Q000172:deficiency / Q000378:metabolism* / Q000494:pharmacology
D015415:Biomarkers; D008668:Metallothionein; D015032:Zinc